---
title: 'Survodutide for treatment of obesity: rationale and design of two randomized
  phase 3 clinical trials (SYNCHRONIZEâ„¢-1 and -2)'
date: '2024-11-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39495965/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241104202650&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: These trials are designed to provide robust evaluation
  of the efficacy, safety, and tolerability of survodutide for the treatment of obesity
  in the presence or absence of ...'
disable_comments: true
---
CONCLUSIONS: These trials are designed to provide robust evaluation of the efficacy, safety, and tolerability of survodutide for the treatment of obesity in the presence or absence of ...